Synapse - Works

Results (4760)

A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis

Meeting Abstract

Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
Blood (2016)

Fulltext@MSK | Save

ENESTgoal treatment-free remission study: Updated preliminary results and digital polymerase chain reaction analysis in patients with chronic myeloid leukemia in chronic phase who switched from imatinib to nilotinib

Meeting Abstract

Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Pinilla-Ibarz, J.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Dautaj, I.; Wolff, J.; more...
Blood (2016)

Fulltext@MSK | Save

Pooled multi-trial analysis of venetoclax efficacy in patients with relapsed or refractory chronic lymphocytic leukemia

Meeting Abstract

Roberts, A. W.; Seymour, J. F.; Eichhorst, B.; Stilgenbauer, S.; Choi, M. Y.; Davids, M. S.; Gerecitano, J. F.; Popovic, R.; Chyla, B.; Zhu, M.; more...
Blood (2016)

Fulltext@MSK | Save

Markers for increased thrombotic risk within the complete blood count

Meeting Abstract

Rognvaldsson, S.; Lund, S. H.; Hultcrantz, M.; Sveinsdottir, S. V.; Eiriksdottir, G.; Harris, T. B.; Guonason, V.; Kristinsson, S. Y.
Blood (2016)

Fulltext@MSK | Save

Analysis of an online decision support tool for chronic lymphocytic leukemia: Disparities in treatment selection between experts and community practitioners

Meeting Abstract

Rosenthal, K. M.; Awan, F. T.; Barrientos, J. C.; Coutre, S. E.; Obholz, K. L.; Zelenetz, A. D.
Blood (2016)

Fulltext@MSK | Save

Hypermethylation of GADD45A defines a methylation profile distinct to mutant IDH1/2, and correlates with more aggressive AML

Meeting Abstract

Samaraweera, S. E.; Garrett-Bakelman, F. E.; Neelamraju, Y.; Perugini, M.; Casolari, D. A.; Iarossi, D.; Bray, S. C.; Sheridan, C.; Lee, T. C.; Tiong, I. S.; more...
Blood (2016)

Fulltext@MSK | Save

CD33-directed chimeric antigen receptor (CAR) T cells for the treatment of acute myeloid leukemia (AML)

Meeting Abstract

Rafiq, S.; Purdon, T. J.; Schultz, L. M.; Brentjens, R. J.
Blood (2016)

Fulltext@MSK | Save

Outcomes of rituximab for EBV viremia/post-transplant lymphoproliferative disease in CD34+ selected allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Poppiti, K.; Lin, A.; Adel, N. G.; Hilden, P.; Castro-Malaspina, H.
Blood (2016)

Fulltext@MSK | Save

Utility of fluorodeoxyglucose positron emission tomography (FDG-PET) and biomarkers, serum vitamin B12 and HDL for assessing lymphoproliferation in children and adults with autoimmune lymphoproliferative syndrome due to FAS mutations (ALPS-FAS)

Meeting Abstract

Rao, V. K.; Price, S.; Dodd, L.; Alan, R.; Whatley, M.; Carrasquillo, J.; Chen, C. C.
Blood (2016)

Fulltext@MSK | Save

Treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) post-hematopoietic stem cell transplantation (HSCT) in patients with acute leukemias: A subgroup analysis from the defibrotide expanded-access program

Meeting Abstract

Richardson, P. G.; Smith, A. R.; Triplett, B. M.; Kernan, N. A.; Grupp, S. A.; Antin, J. H.; Lehmann, L.; Liang, W.; Hume, R.; Tappe, W.; more...
Blood (2016)

Fulltext@MSK | Save